Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Heart failure: Entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.
Clinical judgment should be used in deciding whom to treat as LVEF is a variable measure.
Entresto is administered in place of an ACE inhibitor or ARB.
Hypertension: Entresto is indicated for the treatment of essential hypertension.
Because of the risk of excessive decrease in blood pressure etc., in principle, Entresto should not be used as a first-line drug for the treatment of hypertension.

Entresto Indications/Uses

sacubitril + valsartan

Manufacturer:

Novartis

Distributor:

Zuellig Pharma